rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
17
|
pubmed:dateCreated |
2001-9-4
|
pubmed:abstractText |
To compare health-related quality-of-life outcomes after primary androgen deprivation (AD) therapy with orchiectomy versus luteinizing hormone-releasing hormone (LHRH) agonists for patients with prostate cancer.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0732-183X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
19
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3750-7
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:11533098-Adult,
pubmed-meshheading:11533098-Aged,
pubmed-meshheading:11533098-Aged, 80 and over,
pubmed-meshheading:11533098-Antineoplastic Agents, Hormonal,
pubmed-meshheading:11533098-Cross-Sectional Studies,
pubmed-meshheading:11533098-Gonadotropin-Releasing Hormone,
pubmed-meshheading:11533098-Goserelin,
pubmed-meshheading:11533098-Humans,
pubmed-meshheading:11533098-Leuprolide,
pubmed-meshheading:11533098-Male,
pubmed-meshheading:11533098-Middle Aged,
pubmed-meshheading:11533098-Orchiectomy,
pubmed-meshheading:11533098-Patient Satisfaction,
pubmed-meshheading:11533098-Prostatic Neoplasms,
pubmed-meshheading:11533098-Quality of Life,
pubmed-meshheading:11533098-Regression Analysis,
pubmed-meshheading:11533098-Sexuality
|
pubmed:year |
2001
|
pubmed:articleTitle |
Quality-of-life outcomes after primary androgen deprivation therapy: results from the Prostate Cancer Outcomes Study.
|
pubmed:affiliation |
Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA. potosky@nih.gov
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.
|